A Study of CS3002 in Subjects With Advanced Solid Tumors

Clinical trial NCT04162301 · TERMINATED

Trial details

NCT number: NCT04162301
Sponsor: CStone Pharmaceuticals
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2019-12-30
Primary completion: 2021-02-19
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.